Showing results (821-830 of 1,435) with videos related to
Sort By:
Pageof 144
Journal of Medical Genetics|May 22, 2015
Potential research participants support the return of raw sequence dataAnna Middleton, Caroline F Wright, Katherine I Morley, et al.American Journal of Human Genetics|June 14, 2022
Rare genetic variants in genes and loci linked to dominant monogenic developmental disorders cause milder related phenotypes in the general populationRebecca Kingdom, Marcus Tuke, Andrew Wood, et al.Journal of Medical Genetics|August 27, 2020
Assessing performance of pathogenicity predictors using clinically relevant variant datasetsAdam C Gunning, Verity Fryer, James Fasham, et al.Genome Medicine|July 11, 2024
Genetic constraint at single amino acid resolution in protein domains improves missense variant prioritisation and gene discoveryXiaolei Zhang, Pantazis I Theotokis, Nicholas Li, et al.International Journal of Pharmaceutics|December 30, 2019
Effects of compaction pressure, speed and punch head profile on the ultrasonically-extracted physical properties of pharmaceutical compactsXiaochi Xu, Yigitcan Coskunturk, Vivek S Dave, et al.Letters in Applied Microbiology|October 25, 2013
Prevalence and diversity of Escherichia coli isolated from a barley trial supplemented with bulky organic soil amendments: green compost and bovine slurryN J Holden, F Wright, K Mackenzie, et al.Journal of Virology|April 3, 1998
Viruses and cells with mutations affecting viral entry are selected during persistent rotavirus infections of MA104 cellsJ Z Mrukowicz, J D Wetzel, M I Goral, et al.Vaccine|September 1, 1987
Comparison of live and inactivated influenza vaccine in high risk childrenJ C King, P A Gross, C R Denning, et al.Journal of Virology|June 16, 2005
Growth of respiratory syncytial virus in primary epithelial cells from the human respiratory tractPeter F Wright, Mine R Ikizler, Ricardo A Gonzales, et al.Canadian Journal of Physiology and Pharmacology|August 1, 1997
Differential in vivo and in vitro bronchorelaxant activities of CP-80,633, a selective phosphodiesterase 4 inhibitorK F Wright, C R Turner, R Jayasinghe-Beck, et al.Pageof 144